VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NOVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NOVTNovanta Inc.
$161.72$5.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. NOVT
  4. Financial Ratios

Novanta Inc. (NOVT) Financial Ratios

Latest Ratios: P/E Ratio 110.0x · EV/EBITDA 32.0x · ROE 5.2%. (1998–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

NOVT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$5.8B$4.4B$5.5B$6.1B$4.9B$6.3B$4.2B$3.1B$2.2B$1.8B$733M
Enterprise Value$5.7B$4.3B$5.9B$6.4B$5.3B$6.7B$4.3B$3.3B$2.4B$1.9B$751M
P/E Ratio →110.0180.9586.3183.3765.96125.0694.5876.9044.0644.2533.33
P/S Ratio5.874.455.816.885.678.937.145.023.643.381.91
P/B Ratio4.523.327.409.018.4512.108.847.546.074.922.83
P/FCF118.9290.1839.0460.6168.5987.0932.4959.8729.8032.5018.64
P/OCF89.9168.1834.8250.5353.7566.6830.0649.7024.9327.8315.34

P/E links to full P/E history page with 30-year chart

NOVT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—4.416.197.226.129.467.365.343.843.641.95
EV / EBITDA32.0324.2335.3640.5333.7262.2246.1335.7021.8421.5014.09
EV / EBIT49.0337.1047.2751.6449.0281.4572.7846.4929.8529.1618.36
EV / FCF—89.3741.5763.6074.0692.2833.5063.6231.4734.9719.10

NOVT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin41.6%41.6%44.4%45.4%44.0%42.5%41.4%41.9%42.6%42.3%42.2%
Operating Margin11.9%11.9%11.6%12.5%12.0%9.1%9.5%8.8%11.6%11.0%8.6%
Net Profit Margin5.5%5.5%6.8%8.3%8.6%7.1%7.5%6.5%8.0%11.5%5.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE5.2%5.2%9.0%11.7%13.5%10.1%10.0%10.4%13.5%19.5%8.7%
ROA3.4%3.4%4.9%5.9%6.0%4.8%5.1%5.1%6.8%10.4%5.2%
ROIC7.4%7.4%8.0%8.5%8.3%6.4%6.9%7.5%10.8%11.2%8.7%
ROCE8.3%8.3%9.6%10.2%9.7%7.1%7.5%8.2%11.4%11.7%9.2%

NOVT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.260.260.630.600.850.950.530.660.560.650.33
Debt / EBITDA1.911.912.832.583.134.592.712.951.922.661.61
Net Debt / Equity—-0.030.480.440.670.720.270.470.340.380.07
Net Debt / EBITDA-0.22-0.222.151.912.493.501.382.101.161.520.34
Debt / FCF—-0.812.532.995.475.191.003.751.672.480.46
Interest Coverage5.435.433.954.786.8811.119.098.468.069.098.97

Net cash position: cash ($381M) exceeds total debt ($342M)

NOVT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.693.692.582.982.562.032.662.262.702.932.83
Quick Ratio2.802.801.721.911.531.351.851.391.702.001.98
Cash Ratio1.791.790.680.750.610.641.090.590.791.020.97
Asset Turnover—0.540.680.720.690.580.680.720.850.720.90
Inventory Turnover3.043.043.653.232.873.233.733.123.373.293.72
Days Sales Outstanding—68.8258.0757.7158.3859.7146.3853.1049.8857.0560.49

NOVT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield0.9%1.2%1.2%1.2%1.5%0.8%1.1%1.3%2.3%2.3%3.0%
FCF Yield0.8%1.1%2.6%1.6%1.5%1.1%3.1%1.7%3.4%3.1%5.4%
Buyback Yield0.7%0.9%0.0%0.0%0.2%0.0%0.1%0.3%0.3%0.0%0.2%
Total Shareholder Yield0.7%0.9%0.0%0.0%0.2%0.0%0.1%0.3%0.3%0.0%0.2%
Shares Outstanding—$37M$36M$36M$36M$36M$36M$36M$35M$35M$35M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Acquisition integration and valuation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Valuation Reflects Growth Expectations

Based on current market data, Novanta trades at a forward P/E of 43.89, which suggests that investors are pricing in significant future earnings expansion that may be difficult to sustain given the company's historical volatility in net margins and reliance on inorganic growth strategies.

The current P/E multiple of 107.18 appears elevated relative to the broader industrial sector, implying that the market assigns a premium for its medical technology exposure. However, the PEG ratio of 32.52 warrants caution, as it suggests the current valuation may be disconnected from the actual pace of earnings growth.

Capital Efficiency Constrained by Acquisitions

As reported in financial statements, Novanta's ROIC has remained stagnant between 1.7% and 2.1% over the last ten quarters, indicating that the company's aggressive acquisition strategy has yet to yield the expected compounding returns on invested capital relative to its peers.

The low ROIC suggests that the capital deployed for acquisitions is currently being offset by the high cost of integrating disparate hardware brands. Investors should monitor whether management can improve these returns as the company shifts focus toward operational synergies rather than further expansion.

Working Capital Friction Impacts Liquidity

According to recent SEC filings, Novanta's cash conversion cycle has fluctuated significantly, reaching 124 days in 2026Q1, which highlights the operational challenges of managing long-lead-time inventory within a complex, multi-segment hardware manufacturing business model.

The high days inventory outstanding, which peaked at 123 days in 2023Q4, suggests that the company must maintain substantial buffer stocks to satisfy OEM requirements. This inventory dependence creates persistent pressure on free cash flow and limits the company's overall working capital efficiency.

Deleveraging Enhances Financial Stability

Based on reported figures, Novanta has successfully reduced its debt-to-equity ratio from 0.84 in 2024Q1 to 0.22 in 2026Q1, signaling a disciplined approach to balance sheet management that provides a significant buffer against potential cyclical downturns in the industrial and semiconductor markets.

The improvement in interest coverage, now at 16.36x, indicates that the company is well-positioned to service its remaining debt obligations. This conservative leverage profile provides management with the necessary flexibility to pursue strategic opportunities without the immediate need for dilutive equity financing.

Misapplication of P/E Multiples

The P/E ratio is frequently misapplied to Novanta, as it obscures the significant impact of non-cash amortization charges resulting from the company's serial acquisition strategy, which artificially depresses reported net income and makes the business appear less profitable than its cash-generating capacity suggests.

Analysts should instead focus on EV/EBITDA or cash-flow-based metrics to better evaluate the underlying earning power of the consolidated brands. Relying solely on P/E may lead to an inaccurate assessment of the company's valuation relative to its true operational performance.

Download Financial Ratios Data

Includes 30+ ratios · 28 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NOVT — Frequently Asked Questions

Quick answers to the most common questions about buying NOVT stock.

What is Novanta Inc.'s P/E ratio?

Novanta Inc.'s current P/E ratio is 110.0x. The historical average is 47.0x. This places it at the 95th percentile of its historical range.

What is Novanta Inc.'s EV/EBITDA?

Novanta Inc.'s current EV/EBITDA is 32.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.8x.

What is Novanta Inc.'s ROE?

Novanta Inc.'s return on equity (ROE) is 5.2%. The historical average is 0.3%.

Is NOVT stock overvalued?

Based on historical data, Novanta Inc. is trading at a P/E of 110.0x. This is at the 95th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Novanta Inc.'s profit margins?

Novanta Inc. has 41.6% gross margin and 11.9% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Novanta Inc. have?

Novanta Inc.'s Debt/EBITDA ratio is 1.9x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.